Literature DB >> 33849641

Virtual Care in Rhinology.

Kristine A Smith1, Andrew Thamboo2, Yvonne Chan3, Christopher J Chin4, Megan Werger5, Brian Rotenberg6.   

Abstract

BACKGROUND: The SARS-CoV-2 (COVID) pandemic has resulted in an increase in virtual care. While some specialties are well suited to virtual care, Otolaryngology - Head and Neck Surgery could be limited due to reliance on physical examination and nasal endoscopy, including Rhinology. It is likely virtual care will remain integrated for the foreseeable future and it is important to determine the strengths and weaknesses of this treatment modality for rhinology. <br> METHODS: A survey on virtual care in rhinology was distributed to 61 Canadian rhinologists. The primary objective was to determine how virtual care compared to in-person care in each area of a typical appointment. Other areas focused on platforms used to deliver virtual care and which patients could be appropriately assessed by virtual visits. <br> RESULTS: 43 participants responded (response rate 70.5%). The majority of participants use the telephone as their primary platform. History taking and reviewing results (lab work, imaging) were reported to be equivalent in virtual care. Non-urgent follow up and new patients were thought to be the most appropriate for virtual care. The inability to perform exams and nasal endoscopy were reported to be significant limitations. <br> CONCLUSION: It is important to understand the strengths and limitations of virtual care. These results identify the perceived strengths and weaknesses of virtual care in rhinology, and will help rhinologists understand the role of virtual care in their practices.

Entities:  

Keywords:  COVID-19; Coronavirus; Rhinology; Virtual care

Year:  2021        PMID: 33849641     DOI: 10.1186/s40463-021-00505-1

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


  7 in total

Review 1.  Telehealth Opportunities for the Otolaryngologist: A Silver Lining During the COVID-19 Pandemic.

Authors:  Taha Z Shipchandler; B Ryan Nesemeier; Noah P Parker; Dominic Vernon; Vincent J Campiti; Benjamin P Anthony; Mohamedkazim M Alwani; Elisa A Illing; Jonathan Y Ting
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-19       Impact factor: 3.497

2.  The novel corona virus and rhinology: Impact on practice patterns and future directions.

Authors:  Michael Setzen; Peter F Svider; Sean Setzen; Gavin Setzen; Jean Anderson Eloy; Andrew P Johnson
Journal:  Am J Otolaryngol       Date:  2020-06-01       Impact factor: 1.808

3.  Telehealth as a Bright Spot of the COVID-19 Pandemic: Recommendations From the Virtual Frontlines ("Frontweb").

Authors:  J Nwando Olayiwola; Candy Magaña; Ashley Harmon; Shalina Nair; Erica Esposito; Christine Harsh; L Arick Forrest; Randy Wexler
Journal:  JMIR Public Health Surveill       Date:  2020-06-25

Review 4.  Embracing telemedicine into your otolaryngology practice amid the COVID-19 crisis: An invited commentary.

Authors:  Kim Pollock; Michael Setzen; Peter F Svider
Journal:  Am J Otolaryngol       Date:  2020-04-15       Impact factor: 1.808

5.  Outpatient Otolaryngology in the Era of COVID-19: A Data-Driven Analysis of Practice Patterns.

Authors:  David A Kasle; Sina J Torabi; Emily L Savoca; Benjamin L Judson; R Peter Manes
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-12       Impact factor: 3.497

6.  Head and neck virtual medicine in a pandemic era: Lessons from COVID-19.

Authors:  Aman Prasad; Ryan M Carey; Karthik Rajasekaran
Journal:  Head Neck       Date:  2020-04-22       Impact factor: 3.147

7.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
  7 in total
  1 in total

Review 1.  Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps.

Authors:  Andrea Rampi; Alessandro Vinciguerra; Umberto Tanzini; Mario Bussi; Matteo Trimarchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-13       Impact factor: 3.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.